Welcome To Synterica

Welcome To Synterica

Welcome To SyntericaWelcome To SyntericaWelcome To Synterica

Synterica uses a gene based system to discover proteins for the treatment of  diseases with an emphasis on infectious disease

About Us

Therapeutic Development

 Synterica makes rationally engineered biologics for clinical use.  The engineered biologics are proteins that contain a framework derived from robust antibodies found in camelids (camels, alpacas etc.).  Variable sequences are placed between framework sequences to make engineered biologics.   The process starts with a DNA library having a large binding repertoire.  A selection process is then used to identify proteins with desired properties within that library. Targets are chosen based on selected diseases of interest.

Pre-clinical development is focused on two categories of diseases: infectious diseases and other medical conditions.

Infectious disease targets:

  • Clostridium difficile
  • COVID 19 (SARS-CoV-2)

Other targets:

  • Cancer immunotherapy
  • Cholesterol regulation

Synterica's products are in development and are not FDA approved therapeutics.

Contact Us

Send Message


1448 South Rolling Road, Suite 21, Halethorpe, Maryland 21227, United States